Back to U.S. Bancorp U.S. Bancorp

ARCTARCT

Showing 8 of 29 quarters

Position history for U.S. BancorpU.S. Bancorp's holdings in Arcturus Therapeutics Holdings Inc.

Yes. U.S. Bancorp holds 423 shares of ARCT (Arcturus Therapeutics Holdings), worth $2,843, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. U.S. Bancorp has held ARCT since Q2 2019, across 29 quarterly 13F filings.

Current Value

$2,843

Current Shares

423

Total Value Change

-$22,387

Total Shares Change

-664

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
423
0.0%
$2,8430.0%$6.72
0
2026-Q1
Unchanged
423
0.0%
$3,2660.0%$7.72
0
2025-Q4
Unchanged
423
0.0%
$2,5930.0%$6.13
0
2025-Q3
Decreased
423
-94.6%
$7,7960.0%$18.43
0
2025-Q2
Increased
7,787
+129.5%
$101,3090.0%$13.01
35
2025-Q1
Increased
3,393
+218.9%
$35,9320.0%$10.59
22
2024-Q4
Decreased
1,064
-2.1%
$18,0560.0%$16.97
0
2024-Q3
Decreased
1,087
-7.7%
$25,2300.0%$23.21
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used